Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CMRA

Comera Life Sciences (CMRA)

Comera Life Sciences Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CMRA
일자시간출처헤드라인심볼기업
2024/01/0422:30GlobeNewswire Inc.Comera Life Sciences Announces Bridge Financing and Exercise of Take Private OptionNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/12/0622:30GlobeNewswire Inc.Comera Life Sciences Announces Process Exploring Strategic AlternativesNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/11/1322:00GlobeNewswire Inc.Comera Life Sciences Appoints Dorothy Clarke to Board of DirectorsNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/11/0922:00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/10/1621:00GlobeNewswire Inc.Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/09/1221:00GlobeNewswire Inc.Comera Life Sciences Announces the Completion of $4.1 Million Private PlacementNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/08/1621:00GlobeNewswire Inc.Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing CapabilitiesNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/08/1021:00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/08/0821:00GlobeNewswire Inc.Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ PlatformNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/08/0121:00GlobeNewswire Inc.Comera Life Sciences Announces $4.1 Million Private PlacementNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/07/2021:00GlobeNewswire Inc.Comera Life Sciences Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore ExcipientsNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/05/1121:30GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/04/2721:00GlobeNewswire Inc.Comera Life Sciences to Participate in Four Upcoming ConferencesNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/04/0321:30GlobeNewswire Inc.Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient TechnologyNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/03/1621:00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/02/1403:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMRAComera Life Sciences Holdings Inc
2023/02/0702:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMRAComera Life Sciences Holdings Inc
2023/01/1306:15GlobeNewswire Inc.Comera Life Sciences to Present at 22nd Annual PepTalk ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/01/0522:00GlobeNewswire Inc.Comera Life Sciences to Present at Upcoming Biotech Showcase Investor ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
2023/01/0506:15GlobeNewswire Inc.Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq RulesNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/11/1806:05GlobeNewswire Inc.Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/11/1022:00GlobeNewswire Inc.Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business HighlightsNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/11/0922:00GlobeNewswire Inc.Comera Life Sciences Appoints Janice Marie McCourt as Chief Business OfficerNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/10/1821:00GlobeNewswire Inc.Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 StudyNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/10/0423:30GlobeNewswire Inc.Comera Life Sciences Expands Woburn OperationsNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/09/0105:15GlobeNewswire Inc.Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business SolutionsNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/06/2221:00Business WireComera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore PlatformNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/06/1621:00Business WireComera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial OfficerNASDAQ:CMRAComera Life Sciences Holdings Inc
2022/05/3121:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMRAComera Life Sciences Holdings Inc
 검색 관련기사 보기:NASDAQ:CMRA